2026. The Reply to the Letter to the Editor Regarding: "The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study". Voprosy onkologii. 72, 1 (Mar. 2026), OF-2568. DOI:https://doi.org/10.37469/0507-3758-2026-72-1-OF-2568.